How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Category: Injectibles
Injectibles
Popular
Injectibles
Latest
Merz Aesthetics Receives EU Approval for New BELOTERO Balance Indications
Filler cleared for infraorbital hollow and horizontal forehead lines in Europe.
All
Latest
Acclaro Showcases Next-Gen Fiber Laser for Broad Skin Rejuvenation Applications
The tabletop system builds on the UltraClear platform with multiple treatment modes targeting pigment, texture, and scarring across skin types.
Survey Maps Facial Aesthetic Concerns After GLP-1–Associated Weight Loss
A national survey shows how GLP-1–associated weight loss is driving facial volume loss, laxity, and wrinkles—and why fillers and neuromodulators anchor treatment for this growing patient group. Plastic Surgery Practice talks to one of the study’s authors to break down the findings and what they mean for treatment planning in today’s aesthetic practice.
Read More
Galderma Launches First OBT Hyaluronic Acid Injectables in Japan
Restylane Defyne and Refyne expand the company’s portfolio to four products in the Japanese market, designed for facial wrinkle correction.
Read More
How VYC-12L Performs in Treating Horizontal Neck Lines
A principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.
Read More
FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
Read More
What Recent Studies Reveal About Natural Results With OnabotulinumtoxinA
Two new clinical analyses examine how simultaneous, on-label 64-unit onabotulinumtoxinA treatment of the upper face delivers natural-looking, durable, and predictable outcomes across diverse patient populations and multiple treatment cycles.
Read More
Allergan Aesthetics Presents New Data on Facial Injectable Portfolio at IMCAS 2026
Nine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.
Read More
Australia’s TGA Warns of Continued Imports of Counterfeit Botox
Australia’s drug regulator says counterfeit Botox vials—made to appear as Allergan products—continue to be imported despite a previous warning.
Read More
FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
Read More
Surge in Counterfeit Injectables Prompts Safety Warning from AAFPRS
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
Read More
Hybrid Fillers and Aging Patients Are Reshaping Global Filler Demand
A new analysis points to aging patients, rising med-spa volume, and next-generation HA and biostimulatory formulas as drivers behind the projected jump to an $8.45B global fillers market.
Read More
What’s Fueling—and Slowing—the Global Surge in HA Fillers?
A new report reveals shifting forces behind the rising use of hyaluronic acid fillers worldwide.
Read More
Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E
Presentations highlight investigational trenibotulinumtoxinE in the treatment of glabellar lines and other new findings across the company’s portfolio.
Read More
FDA Warns Websites Over Unapproved Botox Products
The FDA issued 18 warning letters to online sellers of unapproved and misbranded botulinum toxin products linked to serious safety risks.
Read More
FDA Approves Restylane Lyft for Chin Augmentation
Pivotal trial data showed sustained improvement in chin projection and high patient and investigator satisfaction through 12 months.
Read More
Merz Rolls Out New Ergonomic Syringe for Belotero HA Line
The syringe redesign will first be available with select Belotero products in Europe before a phased international launch.
Read More